Skip to main content

Articles By Cassandra Calabrese, DO


Checkpoint Inhibitor-related Myositis – Something Different

24 October 2018

As expected, this year’s ACR meeting saw an upswing in the number of abstracts on immune related adverse events from checkpoint inhibitor therapy compared to last year.

Read Article

The Consequences and Cure of Hepatitis C

26 March 2018

I spent this past week seeing hepatitis C patients with our hepatologists, and being a rheumatologist, I was looking forward to seeing extra-hepatic manifestations of HCV that we read about in text-books - cryoglobulinemic vasculitis, sicca syndrome, porphyria cutanea tarda and many others. I suppose I should not be surprised that the week passed without seeing a single one of these. 

Read Article

Prevention of HBV Infection: How Are We Doing?

18 January 2018

In 2016 the WHO set out to eliminate HBV infection as a public health threat by 2030. So far, we are far from this goal as vaccine implementation has been suboptimal in a number of important patient populations, including patients with rheumatologic diseases, as well as other immunocompromising diseases like HIV.

Read Article

Q Fever - The Intersection of Rheum and ID

02 October 2017

Today in clinic, I saw a patient with longstanding seropositive, erosive rheumatoid arthritis who had been treated with etanercept for over 10 years. She had undergone valve replacement years ago for regurgitation.

Read Article

Why Rheumatologists Should Do Better Vaccinating this Flu Season

12 September 2017

It is well known that influenza infection is more common in patients with rheumatologic diseases. Blumentals et al.

Read Article

CDC: Pneumococcal Vaccination in Adults

19 July 2017

Streptococcus pneumonia is a leading cause of morbidity and mortality in adults; including patients with autoimmune diseases who are at particular risk.

Read Article

Lymphopenia and Steroids Increase the Risk of Pneumocystis Jiroveci in Systemic Rheumatic Diseases

10 July 2017

It is well-known that patients with systemic autoimmune diseases are at risk for Pneumocystis jirovecii pneumonia (PJP) and although infrequent, it carries a high mortality. A new study shows lymphopenia and steroid use increases the risk of PJP.

Read Article

Suspending Methotrexate for Influenza Vaccination

12 June 2017

Vaccinating our rheumatoid arthritis patients against influenza every year is a safety priorty. However immunosuppressive therapies pose a challenge to vaccine administration as their use can hamper vaccine immunogenicity.

Read Article

Venous Thromboembolism Risk Factors in ANCA-Associated Vasculitis

03 May 2017

A retrospective analysis of four European vasculitis trials analyzes the risk venous thromboembolism (VTE) with ANCA-associated vasculitis and shows that CRP, cutaneous and GI involvement and baseline creatinine were most associated with VTE risk.

Read Article

Rheumatic Manifestations Following Chikungunya Infection

24 March 2017

In the Makonde language, “Chikungunya” translates to “that which bends up”, descriptive of the twisted posture of those infected secondary to intense joint and muscle pain experienced during the acute phase of the disease.  

Read Article